| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,271 |
10,051 |
$327K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,534 |
2,782 |
$109K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,852 |
1,493 |
$22K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
181 |
151 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
405 |
341 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
143 |
130 |
$3K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
125 |
112 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,098 |
943 |
$2K |
| 99406 |
|
326 |
288 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
15 |
$889.20 |
| 90756 |
|
44 |
42 |
$720.12 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
61 |
45 |
$708.79 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
56 |
54 |
$564.48 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
457 |
391 |
$500.35 |
| 90688 |
|
33 |
31 |
$399.49 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
45 |
35 |
$300.22 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
15 |
$212.03 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$158.05 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
40 |
29 |
$77.40 |
| 94760 |
|
151 |
137 |
$70.40 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
33 |
25 |
$27.20 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
71 |
61 |
$0.00 |